Balducci-Silano P L, Layrisse Z E
Department of Pathology and Laboratory Medicine, University of Florida, Gainesville 32610-0275, USA.
J Autoimmun. 1995 Jun;8(3):425-37. doi: 10.1006/jaut.1995.0034.
It is known that certain combinations of alleles within the Human Leukocyte Antigen (HLA) Complex are associated with susceptibility or resistance to insulin-dependent diabetes mellitus (IDDM). The association of DR and DQ with IDDM has been well documented. Even though the association of specific DP alleles with some autoimmune diseases (i.e. juvenile rheumatoid arthritis [JRA] and celiac disease) has already been demonstrated, the role of HLA-DP genes in IDDM remains uncertain. A previous study conducted on a group of diabetic Venezuelan families with IDDM proband demonstrated that the HLA-DRB104-DQA103-DQB10302 and DRB103-DQA10501-DQB10201 combinations present a strong association with susceptibility to IDDM. The availability of this population enabled us to assess further susceptibility associated with other HLA class II alleles. We analysed HLA-DPA1 and DPB1 genes of 42 Venezuelan families with one IDDM proband and of 32 healthy families by oligotyping (PCR-SSO) using primers and probes from the XIth Histocompatibility Workshop. In contrast with previous data reported in other populations, the HLA DPA101-DPB10202 was the only haplotype significantly associated with IDDM in the Venezuelan population studied. In most cases the data showed this HLA DP allele combination as a part of the HLA DRB103-DQA10501-DQB10201 haplotype positively associated with IDDM, indicating a linkage disequilibrium between the alleles involved in this HLA DR-DQ-DP haplotype and as a consequence, a secondary role of HLA-DP genes in conferring susceptibility to the development of the disease. The analysis also indicates a non-significant increase of HLA DPA101-DPB10301 and DPA102-DPB11301 haplotypes among diabetics. However, both combinations were in 50% of the cases associated with the HLA DRB104-DQA103-DQB10302 haplotype. These data and their comparison with HLA DR-DQ-DP haplotypes in more homogeneous ethnic groups support the existence of a weak association of IDDM with specific HLA DP alleles and indicate how the distribution of these DP alleles could differ depending on the ethnic groups studied.
众所周知,人类白细胞抗原(HLA)复合体中的某些等位基因组合与胰岛素依赖型糖尿病(IDDM)的易感性或抗性相关。DR和DQ与IDDM的关联已有充分记录。尽管特定DP等位基因与某些自身免疫性疾病(如青少年类风湿性关节炎[JRA]和乳糜泻)的关联已得到证实,但HLA-DP基因在IDDM中的作用仍不确定。先前对一组以IDDM先证者为研究对象的委内瑞拉糖尿病家庭进行的研究表明,HLA-DRB104-DQA103-DQB10302和DRB103-DQA10501-DQB10201组合与IDDM易感性密切相关。这一人群的存在使我们能够进一步评估与其他HLA II类等位基因相关的易感性。我们使用来自第十一届组织相容性研讨会的引物和探针,通过寡核苷酸分型(PCR-SSO)分析了42个有一名IDDM先证者的委内瑞拉家庭和32个健康家庭中的HLA-DPA1和DPB1基因。与其他人群先前报道的数据相反,在我们研究的委内瑞拉人群中,HLA DPA101-DPB10202是唯一与IDDM显著相关的单倍型。在大多数情况下,数据显示这种HLA DP等位基因组合是与IDDM呈正相关的HLA DRB103-DQA10501-DQB10201单倍型的一部分,这表明该HLA DR-DQ-DP单倍型中涉及的等位基因之间存在连锁不平衡,因此,HLA-DP基因在赋予疾病易感性方面起次要作用。分析还表明,糖尿病患者中HLA DPA101-DPB10301和DPA102-DPB11301单倍型有不显著的增加。然而,在50%的病例中,这两种组合都与HLA DRB104-DQA103-DQB10302单倍型相关。这些数据以及它们与更同质种族群体中HLA DR-DQ-DP单倍型的比较支持IDDM与特定HLA DP等位基因存在弱关联,并表明这些DP等位基因的分布可能因所研究的种族群体而异。